Prothena Corp plc

DUN LAOGHAIRE, CO. DUBLIN, L2 · Biotech · Public

Therapeutic antibodies and small molecules targeting misfolded protein diseases

Claim this profile

Follows are private to you and power your alerts

Updated · prothena.com

Sector
Biotech
Headquarters
DUN LAOGHAIRE, CO. DUBLIN, L2
Latest Form D
$50M, Mar 2018
Total capital
$50M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$50M
1 Form D · last Mar 2018
103 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

2018FEDERAL ↑EQUITY ↓Cumulative $50M1st Form D$50M
2018FEDERAL ↑EQUITY ↓Cumulative $50M1st Form D$50M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$50M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Anders O. Harfstrand, M.D., Ph.D.DirectorNamed in SEC Form D filings
  • Arthur W. HomanExecutive OfficerNamed in SEC Form D filings
  • Carol D. KarpExecutive OfficerNamed in SEC Form D filings
  • Christopher S. Henney, Ph.D., D.Sc.DirectorNamed in SEC Form D filings
  • Dennis J. SelkoeDirectorNamed in SEC Form D filings
  • Gene G. Kinney, Ph.D.Executive Officer, DirectorNamed in SEC Form D filings
Show all 13 people
  • Karin L. WalkerExecutive OfficerNamed in SEC Form D filings
  • Lars G. Eckman, M.D., Ph.D.DirectorNamed in SEC Form D filings
  • Richard T. CollierDirectorNamed in SEC Form D filings
  • Shane M. CookeDirectorNamed in SEC Form D filings
  • Tara B. Nickerson, Ph.D.Executive OfficerNamed in SEC Form D filings
  • Tran B. NguyenExecutive OfficerNamed in SEC Form D filings
  • Wagner M. Zago, Ph.D.Executive OfficerNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .